[Corrigendum] Novel polygodial analogs P3 and P27: Efficacious therapeutic agents disrupting mitochondrial function in oral squamous cell carcinoma
Author(s) -
Jorge J. De La Chapa,
Prajjal K. Singha,
Mckay Sallaway,
Kristen Self,
Ranna� Nasreldin,
Ramesh Dasari,
Matthew J. Hart,
Alexander Kornienko,
Jérémy Just,
Jason A. Smith,
Alex C. Bissember,
Cara B. Gonzales
Publication year - 2020
Publication title -
international journal of oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.405
H-Index - 122
ISSN - 1019-6439
DOI - 10.3892/ijo.2020.4978
Subject(s) - regret , basal cell , cancer , function (biology) , molecular medicine , drug discovery , library science , oncology , cancer research , medicine , biology , bioinformatics , cell cycle , computer science , genetics , machine learning
After the publication of the above article, the authors have realized that they failed to properly acknowledge the work performed by their Center for Innovative Drug Discovery High Throughput Screening Core Facility in the paper. The Declarations section of their paper should therefore have also included the following statement: "The UT Health San Antonio Center for Innovative Drug Discovery HTS Facility was funded in part by the Cancer Prevention Research Institute of Texas (CPRIT; grant no. RP160844)". The authors regret their oversight in failing to include this information in the Declarations section of their paper. [the original article was published in International Journal of Oncology 53: 2627-2636, 2018; DOI: 10.3892/ijo.2018.4585].
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom